Á lódáil...
Antibody-drug conjugates: Intellectual property considerations
Antibody-drug conjugates are highly complex entities that combine an antibody, a linker and a toxin. This complexity makes them demanding both technically and from a regulatory point of view, and difficult to deal with in their patent aspects. This article discusses different issues of patent protec...
Na minha lista:
| Foilsithe in: | MAbs |
|---|---|
| Príomhúdar: | |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
Taylor & Francis
2015
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4966491/ https://ncbi.nlm.nih.gov/pubmed/26292154 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2015.1082019 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|